Logo

Asuragen

Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay

The project will leverage Asuragen's long-range PCR and Oxford Nanopore's sequencing capabilities to develop a sequencing workflow for carrier screening.

Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says
Premium

The deal with Thermo Fisher is for the development of Bio-Techne's second test in its Exosome Diagnostics portfolio, a multigene assay for kidney transplant rejection.

In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences

News items for the week of April 5, 2021.

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

Bio-Techne said Asuragen's headquarters in Austin, Texas includes a scalable 50,000-square-foot manufacturing facility and CLIA-certified laboratory.

Aug 3, 2020

Pacific Biosciences, Asuragen Collaborate on Clinical Assays

Jul 7, 2020

Asuragen Receives CE Mark for Spinal Muscular Atrophy Assay

Feb 23, 2020

Asuragen Fragile X Diagnostic Test Gets FDA Authorization

Nov 25, 2019

Asuragen, Wave Life Sciences to Develop Companion Diagnostics for Huntington's Disease Therapies

Dec 4, 2018

Asuragen Myotonic Dystrophy 1 Dx Kit Receives CE Mark

Nov 13, 2018

Health Canada Approves Two BCR-ABL Tests

Oct 22, 2018

Asuragen, RTI Collaborate on Fragile X Syndrome Testing

Oct 19, 2018

People in the News: Mary Padbury, Katherine Bach Kalin, Daniel Kolk, More

Sep 7, 2018

Asuragen ALS, Dementia Assay Gets Favorable Evaluation From UPenn Team
Premium

Sep 7, 2018

New Products Posted to GenomeWeb: Genoptix, Asuragen

Sep 5, 2018

Asuragen Gets CE Mark for QuantideX NGS Oncology Panel

Jul 27, 2018

New Products Posted to GenomeWeb: SeraCare, Asuragen, Biofortuna, More

Jun 1, 2018

New Products Posted to GenomeWeb: PerkinElmer, Phase Genomics, Pacific Biosciences, Asuragen, More

Jan 17, 2018

Asuragen Gets CE Mark for QuantideX BCR-ABL Kits on Roche Platform

Feb 21, 2017

Asuragen to Develop IVD Kits on Thermo Fisher Scientific's CE Platform

Dec 12, 2016

Asuragen Research Correlates FMR1 Methylation, Symptoms in Fragile X-Associated Motor Disorder
Premium

Jul 25, 2016

Asuragen BCR-ABL Kit Granted FDA Premarket Clearance

May 19, 2016

Surgical Decisions for Thyroid Nodules Often Not Affected By Molecular Testing

Sep 9, 2015

Illumina, Asuragen to Collaborate on Companion Diagnostics Development

Jun 11, 2015

Asuragen BCR-ABL Assay Receives CE Mark

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.